Vitamin K: Infection, Inflammation, and Auto-Immunity
Yuanyuan Xie,Shifang Li,Dinan Wu,Yining Wang,Jiepeng Chen,Lili Duan,Shuzhuang Li,Yuyuan Li
DOI: https://doi.org/10.2147/jir.s445806
IF: 4.5
2024-02-20
Journal of Inflammation Research
Abstract:Yuanyuan Xie, 1, &ast Shifang Li, 1, &ast Dinan Wu, 2 Yining Wang, 2 Jiepeng Chen, 3 Lili Duan, 3 Shuzhuang Li, 4 Yuyuan Li 2 1 The First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China; 2 Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, People's Republic of China; 3 Sungen Bioscience Co., Ltd, Guangdong, People's Republic of China; 4 College of Basic Medical Science, Dalian Medical University, Dalian, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yuyuan Li; Shuzhuang Li, Tel +86 411 86118983, Email ; Vitamin K (VK) comprises a group of substances with chlorophyll quinone bioactivity and exists in nature in the form of VK1 and VK2. As its initial recognition originated from the ability to promote blood coagulation, it is known as the coagulation vitamin. However, based on extensive research, VK has shown potential for the prevention and treatment of various diseases. Studies demonstrating the beneficial effects of VK on immunity, antioxidant capacity, intestinal microbiota regulation, epithelial development, and bone protection have drawn growing interest in recent years. This review article focuses on the mechanism of action of VK and its potential preventive and therapeutic effects on infections (eg, asthma, COVID-19), inflammation (eg, in type 2 diabetes mellitus, Alzheimer's disease, Parkinson's disease, cancer, aging, atherosclerosis) and autoimmune disorders (eg, inflammatory bowel disease, type 1 diabetes mellitus, multiple sclerosis, rheumatoid arthritis). In addition, VK-dependent proteins (VKDPs) are another crucial mechanism by which VK exerts anti-inflammatory and immunomodulatory effects. This review explores the potential role of VK in preventing aging, combating neurological abnormalities, and treating diseases such as cancer and diabetes. Although current research appoints VK as a therapeutic tool for practical clinical applications in infections, inflammation, and autoimmune diseases, future research is necessary to elucidate the mechanism of action in more detail and overcome current limitations. Keywords: vitamin K, VK-dependent proteins, infection, inflammation, auto-immune disease Infectious diseases pose a significant global health challenge. 1 The human immune system responds to harmful foreign invaders and internal mutations, employing defense mechanisms to counteract such assaults. 2 As we age, the immune system undergoes a process of development, maturation, and senescence, characterized by a progressive decline in immune function associated with an increased frequency of infections and chronic inflammation. 3 Compared to healthy adults, children, the elderly, and patients with chronic disease and autoimmune disorders are more susceptible to pathogen invasion due to their weakened immune system. Therefore, further research is required to strengthen the development of effective drugs for immunity enhancement and pathogen infection resistance. Vitamins are essential nutrients for a healthy body and the proper functioning of the immune system. Vitamins are subdivided into two groups: water-soluble (C and B-complex vitamins) and fat-soluble (vitamins A, D, E, and K). Vitamin K (VK), discovered by Danish biochemist Henrik Dam in the 1930s, is composed of phylloquinone and menaquinone and found in a wide variety of plant and animal products. 4 In addition to the well-established biological function in blood coagulation, 5 it has also shown some beneficial effects in immune response and anti-inflammation. However, to our knowledge, there is no review providing a comprehensive summary in this regard. Thus, we searched the online databases PubMed, Web of Sciences, Scopus, Google Scholar and Science Direct for literature on the effects of VK in infections (eg, asthma, COVID-19), inflammation (eg, in type 2 diabetes mellitus (T2DM), Alzheimer's disease (AD), Parkinson's disease (PD), cancer, aging, atherosclerosis) and autoimmune disorders (eg, inflammatory bowel disease (IBD), type 1 diabetes mellitus (T1DM), multiple sclerosis (MS), and rheumatoid arthritis (RA)). This review aims to summarize the current literature regarding the implications of VK supplementation in infections and the immune response, including evidence from both preclinical and clinical studies. VK can be derived from natural sources and chemical synthesis. Two types of VK occur in nature: VK1 and VK2. VK1 (phylloquinone) is mainly present in leafy or flowering vegetables and vegetable oils. 6 VK2 consists of a group of menaquinones (MK-n, wherein n represents the number of isoprenyl re -Abstract Truncated-
immunology